1. Home
  2. CRGY vs RDY Comparison

CRGY vs RDY Comparison

Compare CRGY & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGY
  • RDY
  • Stock Information
  • Founded
  • CRGY 1986
  • RDY 1984
  • Country
  • CRGY United States
  • RDY India
  • Employees
  • CRGY N/A
  • RDY N/A
  • Industry
  • CRGY Oil & Gas Production
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRGY Energy
  • RDY Health Care
  • Exchange
  • CRGY Nasdaq
  • RDY Nasdaq
  • Market Cap
  • CRGY 2.5B
  • RDY 2.1B
  • IPO Year
  • CRGY N/A
  • RDY N/A
  • Fundamental
  • Price
  • CRGY $9.03
  • RDY $15.08
  • Analyst Decision
  • CRGY Buy
  • RDY Strong Buy
  • Analyst Count
  • CRGY 12
  • RDY 2
  • Target Price
  • CRGY $16.40
  • RDY $16.95
  • AVG Volume (30 Days)
  • CRGY 3.3M
  • RDY 1.8M
  • Earning Date
  • CRGY 08-04-2025
  • RDY 07-28-2025
  • Dividend Yield
  • CRGY 5.36%
  • RDY 0.54%
  • EPS Growth
  • CRGY N/A
  • RDY 1.47
  • EPS
  • CRGY N/A
  • RDY 0.79
  • Revenue
  • CRGY $3,223,618,000.00
  • RDY $3,809,801,863.00
  • Revenue This Year
  • CRGY $25.73
  • RDY $10.24
  • Revenue Next Year
  • CRGY N/A
  • RDY N/A
  • P/E Ratio
  • CRGY N/A
  • RDY $19.14
  • Revenue Growth
  • CRGY 31.58
  • RDY 16.61
  • 52 Week Low
  • CRGY $6.83
  • RDY $12.26
  • 52 Week High
  • CRGY $16.94
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • CRGY 50.03
  • RDY 57.95
  • Support Level
  • CRGY $8.48
  • RDY $15.12
  • Resistance Level
  • CRGY $9.61
  • RDY $15.71
  • Average True Range (ATR)
  • CRGY 0.34
  • RDY 0.19
  • MACD
  • CRGY -0.06
  • RDY -0.07
  • Stochastic Oscillator
  • CRGY 38.36
  • RDY 31.90

About CRGY Crescent Energy Company

Crescent Energy Co is an independent energy company with a portfolio of assets in key basins across the lower 48 states. The company maintains a diverse portfolio of assets in key basins across the United States, including the Eagle Ford, Rockies, Barnett, Permian, and Mid-Con. It seeks to deliver attractive risk-adjusted investment returns and predictable cash flows across cycles with a focus on operated oil and gas assets complemented by non-operated assets, mineral and royalty interests, and midstream infrastructure.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: